Clinical Trials in Baltimore

Showing 5761-5780 of 23,476 trials

Evaluation of an Investigational Wearable Vital Signs Monitoring Device in Healthy Infants

NCT05910320

The primary objective of this study is to evaluate the feasibility of the use of an investigational wearable vital sign monitoring device in infants.

Congenital Heart Disease in Children

Johns Hopkins University3 participantsStarted May 2023

Baltimore, Maryland, United States

Active Not Recruiting< 1 mile

Magnetic Resonance Imaging and Spectroscopy Biomarkers for Facioscapulohumeral Muscular Dystrophy

NCT01671865

The purpose of this research study is to identify and study changes in muscle in people with facioscapulohumeral muscular dystrophy using magnetic resonance imaging and spectroscopy.

Facioscapulohumeral Muscular Dystrophy

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.75 participantsStarted Mar 2012

Baltimore, Maryland, United States

RECRUITINGPhase 38.9 miles

The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)

NCT06520345

The purpose of this study is to evaluate the efficacy and safety of 177Lu-TLX591 in patients with metastatic castration-resistant prostate cancer who have progressed following treatment with Androgen Receptor Pathway Inhibitor Treatment

Metastatic Castration-resistant Prostate Cancer

Telix Pharmaceuticals (Innovations) Pty Limited430 participantsStarted Jul 2024

Orange, California, United States • Miami, Florida, United States • Glen Burnie, Maryland, United States +12 more locations

Evaluation of an Investigational Wearable Vital Signs Monitoring Device in Healthy Infants

Magnetic Resonance Imaging and Spectroscopy Biomarkers for Facioscapulohumeral Muscular Dystrophy

The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)

Find Trials by Condition in Baltimore

Study of mRNA-1010 Seasonal Influenza Vaccine in Adults

Testicular Evaluation of Azoospermia Using Micro-Ultrasound

Evaluation of the Safety and Pharmacokinetics of Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Combination Ophthalmic Solution

Study of Front Line Pembrolizumab and Valemetostat in PD-L1 Positive, HPV-Negative Recurrent/Metastatic Squamous Cell Carcinoma (SCC) of the Head and Neck: The PANTHERAS

Evaluation of The Food Allergy Mastery Program

Study of Front Line Therapy With Nivolumab and Salvage Nivolumab + Ipilimumab in Patients With Advanced Renal Cell Carcinoma

Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients

An Open-label Extension Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis

Pivotal Study to Assess Safety and Performance of Neola®, a Novel Lung Monitoring Device for Neonates

A Study to Investigate the Safety and Efficacy of TMP-301 Compared to Placebo in Adult Patients With Alcohol Use Disorder

MCG as a Noninvasive Diagnostic Strategy for Suspected INOCA (MICRO2)

AMG 176 First in Human Trial in Participants With Relapsed or Refractory Multiple Myeloma and Participants With Relapsed or Refractory Acute Myeloid Leukemia

89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors

Observational Maternal COVID-19 Vaccination Study

Study of KITE-222 in Participants With Relapsed/Refractory Acute Myeloid Leukemia

LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19)

AutoInflammatory Disease Alliance Registry (AIDA)